Bárður Sigurgeirsson

University of Iceland — IS

Medicine · Health Sciences

52h-index14.7kcitations171works6.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Nail Diseases and Treatments(54), Psoriasis: Treatment and Pathogenesis(39), Plant Pathogens and Fungal Diseases(32), Fungal Infections and Studies(31), Dermatology and Skin Diseases(29)

Publications171 total

Relative survival analysis of Merkel cell carcinoma across intersectional demographics using the Surveillance, Epidemiology, and End Results (SEER) database
JAAD International·2025Open Access
The incidence and impact of melanoma subtypes in Iceland 1955–2023
British Journal of Dermatology·2025
A genome-wide association meta-analysis links hidradenitis suppurativa to common and rare sequence variants causing disruption of the Notch and Wnt/β-catenin signaling pathways
Journal of the American Academy of Dermatology·2024· 10 citedOpen Access
Gene-based burden tests of rare germline variants identify six cancer susceptibility genes
Nature Genetics·2024· 15 citedOpen Access
A partial loss-of-function variant in STAT6 protects against type 2 asthma
Journal of Allergy and Clinical Immunology·2024· 5 citedOpen Access
Data from Loss-of-Function Variants in the Tumor-Suppressor Gene <i>PTPN14</i> Confer Increased Cancer Risk
2023Open Access
Supplementary Material from Loss-of-Function Variants in the Tumor-Suppressor Gene <i>PTPN14</i> Confer Increased Cancer Risk
2023Open Access
Data from Loss-of-Function Variants in the Tumor-Suppressor Gene <i>PTPN14</i> Confer Increased Cancer Risk
2023Open Access
Supplementary Material from Loss-of-Function Variants in the Tumor-Suppressor Gene <i>PTPN14</i> Confer Increased Cancer Risk
2023Open Access
Position statement: Recommendations on the diagnosis and treatment of <i>Malassezia</i> folliculitis
Journal of the European Academy of Dermatology and Venereology·2023· 14 citedOpen Access
Secukinumab long-term efficacy and safety in psoriasis through to year 5 of treatment: results of a randomized extension of the phase III ERASURE and FIXTURE trials
British Journal of Dermatology·2022· 41 citedOpen Access
Secukinumab demonstrates efficacy, safety, and tolerability upon administration by 2 ml autoinjector in adult patients with plaque psoriasis: 52‐week results from MATURE, a randomized, placebo‐controlled trial
Dermatologic Therapy·2021· 14 cited
L’administration du sécukinumab par un auto-injecteur de 2 mL démontre une efficacité élevée avec une sécurité et une tolérance comparables chez les patients adultes atteints de psoriasis en plaques : résultats à 16 semaines de l’étude MATURE
Annales de Dermatologie et de Vénéréologie - FMC·2021
Re: "Petite" bit of vital information still missing
2021
Keratinocytes secrete multiple inflammatory and immune biomarkers, which are regulated by LL‐37, in a psoriasis mimicking microenvironment
Scandinavian Journal of Immunology·2021· 15 citedOpen Access
27599 Secukinumab administration by a 2 mL autoinjector demonstrates high efficacy with comparable safety and tolerability in adult patients with plaque psoriasis: 16-week results from MATURE
Journal of the American Academy of Dermatology·2021· 5 cited
27519 Efficacy, pharmacokinetics, and tolerability of subcutaneous secukinumab injections with 2 mL prefilled syringes (300 mg) in adult subjects with moderate to severe plaque psoriasis
Journal of the American Academy of Dermatology·2021
Secukinumab demonstrates efficacy, safety and tolerability upon administration by 2 mL autoinjector in adult patients with plaque psoriasis: 52-week results from MATURE, a randomized, placebo-controlled trial
Data Archiving and Networked Services (DANS)·2021· 3 citedOpen Access
Efficacy, tolerability, patient usability, and satisfaction with a 2 mL pre-filled syringe containing secukinumab 300 mg in patients with moderate to severe plaque psoriasis: results from the phase 3 randomized, double-blind, placebo-controlled ALLURE study
Journal of Dermatological Treatment·2021· 17 citedOpen Access
Emerging antifungal treatment failure of dermatophytosis in Europe: take care or it may become endemic
Journal of the European Academy of Dermatology and Venereology·2021· 108 cited
page 1 of 9Next →

Frequent Co-authors

Jón Ólafsson(15), Patrick Sulem(11), Daníel F. Guðbjartsson(11), Simon Stacey(11), Kristrún R. Benediktsdóttir(11), Guðmar Þorleifsson(10), Kristin Thorisdottir(10), Augustine Kong(10), Unnur Þorsteinsdóttir(10), Kāri Stefánsson(10), Þórunn Rafnar(9), Rafn Ragnarsson(9), Eduardo Nagore(8), José Mayordomo(8), Lambertus A. Kiemeney(7), Jūlı́us Guðmundsson(7), Ásgeir Sigurðsson(7), Péter Rudnai(7), Eugen Gurzău(7), Kvetoslava Koppová(7)